RxDoctor Payments Data

Glenn Black, MD

Cardiovascular Disease · Barberton, OHNPI 1700860970

Payments from drug & device makers

$865in general payments, 2019–2025

Across 65 payments — averaging $13.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$199
  • Amarin Pharma, Inc.$160
  • Merck$136
  • AstraZeneca$98
  • Johnson & Johnson$84
  • Novartis$83
  • plus $105 from 4 others

What the payments were for

  • Food & beverage$865100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$865 in reported general payments places this provider in the 35th percentile of 827 cardiovascular disease providers in Ohio.

See all cardiovascular disease providers in Ohio

Medicare billing

Part B allowed, 2024
$38,397
Medicare patients
144
Services billed
545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban131$148,182
XareltoRivaroxaban56$77,383
EntrestoSacubitril/Valsartan44$50,367
OzempicSemaglutide18$17,131
JardianceEmpagliflozin17$15,723
BrilintaTicagrelor16$12,472
MultaqDronedarone Hcl13$10,308
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,633
Combivent RespimatIpratropium/Albuterol Sulfate14$6,975
SymbicortBudesonide/Formoterol Fumarate18$5,193
Ranolazine ErRanolazine46$4,281
Mesalamine13$3,850
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$2,648
Metoprolol Succinate200$2,639
Albuterol Sulfate HfaAlbuterol Sulfate77$2,401

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$31$148,182131 claims
Johnson & JohnsonXarelto$84$77,38356 claims
NovartisEntresto$83$50,36744 claims
AstraZenecaBrilinta, Symbicort$98$17,66534 claims
Novo NordiskOzempic$37$17,13118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 827 cardiovascular disease providers in Ohio.

Other cardiovascular disease in Barberton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →